The QuayStreet Income Fund has been issued a “4 IP” rating by Research IP, with a score of 3.50/5.
The QuayStreet Income Fund (“the Fund”) invests in a diversified portfolio with an emphasis on income producing assets which may include listed property, equities and derivatives. The investment objective is to provide returns above the Fund’s benchmark taking into account the prevailing short-term interest rates while preserving the real value of investments relative to inflation. The Fund aims to make quarterly distributions. Investment returns may vary from year to year and may be negative.
What is the Fund’s competitive advantage?
Qualitative Research Report and Data Tear Sheet
Research IP says
“The QuayStreet Income Fund provides a sound offering in the diversified income space within the New Zealand managed funds market. The fund offers a lower risk option within its New Zealand peer group with excellent liquidity.“
“Portfolio manager, Roy Cross, exhibits in-depth knowledge of the New Zealand fixed interest space from a bottom-up perspective and a strong focus on the risk versus return arguments when investing in fixed interest securities.“
“The Manager aims to balance risk and return across the allowable range of assets. The allocation to risk is not just about the equity allocation. There is a concentrated effort by the Manager to assess volatility at the security level, which consequently flows through to the Fund level, giving it defensive qualities you’d expect for a Fund with a conservative profile.“
“In terms of risk, a key threat will be inflation currently. The Manager has the ability to invest in inflation-linked bonds to help mitigate this risk. On the equity side, the Manager will consider companies that have pricing power, for example REITs.”
Research IP, 28 July 2021
If you have any questions in relation to this report or the Research IP services, please contact us here.
Disclaimer, Disclosures and Warnings
Research IP strongly recommends this document and report be read in conjunction with the relevant Product Disclosure Statement. Research IP gives no warranty of accuracy or completeness of information in this document. Any information, opinions, views or recommendations are general information only and do not take into consideration any person’s particular financial situation or goals and therefore does not constitute financial advice. This document should not be relied upon as a substitute for financial advice from your financial adviser.